Bedaquiline Properties Analysis
The question asks to identify the statement that is NOT true about Bedaquiline (BDQ). Bedaquiline is a crucial drug in tuberculosis (TB) treatment.
Identifying the Incorrect Statement
- Option B: It is a bacteriostatic drug - This statement is incorrect. Bedaquiline (BDQ) is classified as a bactericidal agent, meaning it actively kills Mycobacterium tuberculosis, rather than just inhibiting its growth.
Rationale for Correctness of Other Options
The following statements are true regarding Bedaquiline:
-
Option 1: It specifically targets mycobacterial ATP synthase - BDQ's primary mechanism of action involves inhibiting the proton pump of the mycobacterial ATP synthase enzyme. This disrupts the bacterium's energy production.
-
Option 3: It has extended half life - Bedaquiline possesses a long elimination half-life, approximately 5.5 months. This characteristic allows for intermittent dosing regimens.
-
Option 4: It has high volume of tissue distribution - Clinical studies show that BDQ distributes extensively into various body tissues, which is consistent with its pharmacological profile.
Therefore, the only statement that is false about Bedaquiline is that it is a bacteriostatic drug.